Study ID,,author,,data source,diag_defn,diag,bronchod,sample_size,case,risk factor,risk_fac,reference group,effect estimate,uni_odds_ratio,uni_lower_ci,uni_upper_ci,Self-calculated,multi_odds_ratio,multi_lower_ci,multi_upper_ci,Variables adjusted for,case with exposure,case without exposure,control with exposure,control without exposure
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,bmi,obese,normal 20-24.9,OR,2.6,1.3,5.2,no,1.52,0.87,2.65,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,bmi,overweight,normal 20-24.9,OR,1.8,0.9,3.3,no,,,,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,comorbidity,cvd,,OR,2.7,1.5,4.9,no,1.6,0.84,3.04,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,comorbidity,diabetes,,OR,4.3,2.1,8.7,no,2.39,1.08,5.27,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,comorbidity,hypertension,no hypertension,OR,2.4,1.5,4,no,1.55,0.89,2.72,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,gender,male,female,OR,1.4,0.9,2.3,no,,,,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,smoking,current,non,OR,1.5,0.8,2.9,no,1.71,0.85,3.44,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
65,Backman 2016,Backman et. al. (2016),https://dx.doi.org/10.1016/j.rmed.2016.10.005,original,gold,rsp,no,726,76,smoking,ex,non,OR,1.3,0.8,2.1,no,,,,"age>60, current smoker, pack years >20, occupational exposure to gase, dust, Manual workers in industry, ischemic heart comorbidity, any heart comorbidity, diabetes, rheumatic comorbidity, hypertension, obesity,overweight and/or obese",,,,
255,Domingo-Relloso 2022,Domingo-Relloso et. al. (2022),https://dx.doi.org/10.1186/s13148-022-01294-8,Strong Heart Study cohort,gold,rsp,no,1677,229,comorbidity,tuberculosis,no prior TB,OR,1.29,0.86,1.94,yes,,,,,34,195,132,964
255,Domingo-Relloso 2022,Domingo-Relloso et. al. (2022),https://dx.doi.org/10.1186/s13148-022-01294-8,Strong Heart Study cohort,gold,rsp,no,1677,229,gender,female,male,OR,1.42,1.05,1.93,yes,,,,,160,69,680,416
255,Domingo-Relloso 2022,Domingo-Relloso et. al. (2022),https://dx.doi.org/10.1186/s13148-022-01294-8,Strong Heart Study cohort,gold,rsp,no,1677,229,smoking,current,non,OR,0.84,0.6,1.18,yes,,,,,80,85,395,351
255,Domingo-Relloso 2022,Domingo-Relloso et. al. (2022),https://dx.doi.org/10.1186/s13148-022-01294-8,Strong Heart Study cohort,gold,rsp,no,1677,229,smoking,ex,non,OR,0.76,0.53,1.08,yes,,,,,64,85,351,351
284,Eriksson 2013,Eriksson et. al. (2013),https://dx.doi.org/10.1016/j.rmed.2012.09.011,original - as part of Obstructive Lung comorbidity in Northern Sweden (OLIN) studies,gold,rsp,no,642,18,comorbidity,heart_failure,no hf,OR,7.78,0.82,73.36,yes,,,,,1,17,4,529
284,Eriksson 2013,Eriksson et. al. (2013),https://dx.doi.org/10.1016/j.rmed.2012.09.011,original - as part of Obstructive Lung comorbidity in Northern Sweden (OLIN) studies,gold,rsp,no,642,18,comorbidity,hypertension,no hypertension,OR,2.6,0.95,7.11,yes,,,,,6,12,86,447
284,Eriksson 2013,Eriksson et. al. (2013),https://dx.doi.org/10.1016/j.rmed.2012.09.011,original - as part of Obstructive Lung comorbidity in Northern Sweden (OLIN) studies,gold,rsp,no,642,18,gender,female,male,OR,0.87,0.35,2.17,yes,,,,,9,10,270,260
284,Eriksson 2013,Eriksson et. al. (2013),https://dx.doi.org/10.1016/j.rmed.2012.09.011,original - as part of Obstructive Lung comorbidity in Northern Sweden (OLIN) studies,gold,rsp,no,642,18,gender,male,female,OR,1.15,0.46,2.89,yes,1.31,0.42,4.12,"sex, age, smoking habits, family history of obstructive airway comorbidity (i.e., chronic bronchitis, emphysema, or asthma among parents or siblings), socio-economic status, and BMI",10,9,260,270
284,Eriksson 2013,Eriksson et. al. (2013),https://dx.doi.org/10.1016/j.rmed.2012.09.011,original - as part of Obstructive Lung comorbidity in Northern Sweden (OLIN) studies,gold,rsp,no,642,18,smoking,current,non,OR,1.42,0.49,4.08,yes,1.94,0.63,5.96,"sex, age, smoking habits, family history of obstructive airway comorbidity (i.e., chronic bronchitis, emphysema, or asthma among parents or siblings), socio-economic status, and BMI",6,9,123,262
284,Eriksson 2013,Eriksson et. al. (2013),https://dx.doi.org/10.1016/j.rmed.2012.09.011,original - as part of Obstructive Lung comorbidity in Northern Sweden (OLIN) studies,gold,rsp,no,642,18,smoking,ex,non,OR,0.8,0.24,2.64,yes,0.62,0.14,2.22,"sex, age, smoking habits, family history of obstructive airway comorbidity (i.e., chronic bronchitis, emphysema, or asthma among parents or siblings), socio-economic status, and BMI",4,9,146,262
297,Fimognari 2007,Fimognari et. al. (2007),https://dx.doi.org/10.1093/gerona/62.7.760,original,gold,rsp,not mentioned,159,25,comorbidity,heart_failure,no HF,OR,2.33,0.72,7.55,yes,,,,,5,20,10,93
297,Fimognari 2007,Fimognari et. al. (2007),https://dx.doi.org/10.1093/gerona/62.7.760,original,gold,rsp,not mentioned,159,25,gender,female,male,OR,1.92,0.74,4.99,yes,,,,,18,7,59,44
297,Fimognari 2007,Fimognari et. al. (2007),https://dx.doi.org/10.1093/gerona/62.7.760,original,gold,rsp,not mentioned,159,25,gender,male,female,OR,0.52,0.2,1.36,yes,,,,,7,18,44,59
352,Guerra 2010,Guerra et. al. (2010),https://dx.doi.org/10.1136/thx.2009.126052,Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD),gold,rsp,no,2048,249,bmi,obese,not obese <30,OR,2.16,1.43,3.27,yes,,,,,34,215,102,1403
352,Guerra 2010,Guerra et. al. (2010),https://dx.doi.org/10.1136/thx.2009.126052,Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD),gold,rsp,no,2048,249,comorbidity,asthma,no asthma,OR,1.84,1.23,2.74,yes,,,,,35,214,123,1381
352,Guerra 2010,Guerra et. al. (2010),https://dx.doi.org/10.1136/thx.2009.126052,Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD),gold,rsp,no,2048,249,comorbidity,diabetes,no diabetes,OR,2.51,1.43,4.41,yes,,,,,18,231,45,1460
352,Guerra 2010,Guerra et. al. (2010),https://dx.doi.org/10.1136/thx.2009.126052,Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD),gold,rsp,no,2048,249,comorbidity,stroke,no stroke,OR,5.74,2.81,11.71,yes,,,,,15,234,17,1488
352,Guerra 2010,Guerra et. al. (2010),https://dx.doi.org/10.1136/thx.2009.126052,Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD),gold,rsp,no,2048,249,gender,female,male,OR,1.58,1.19,2.1,yes,,,,,167,82,847,658
352,Guerra 2010,Guerra et. al. (2010),https://dx.doi.org/10.1136/thx.2009.126052,Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD),gold,rsp,no,2048,249,gender,male,female,OR,0.63,0.48,0.84,yes,,,,,82,167,658,847
389,Higbee 2022,Higbee et. al. (2022),,UK Biobank 2006-2010,gold,prism,no,351874,38639,age,continuous_age,,OR,,,,,1,0.99,1.01,"age, sex, BMI, smoking status, hypertension",,,,
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,bmi,obese,normal 18.5-24.9,,,,,,2.4,2.26,2.55,"age, sex, BMI, smoking status, hypertension",,,,
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,bmi,overweight,normal 18.5-24.9,OR,,,,,1.3,1.23,1.37,"age, sex, BMI, smoking status, hypertension",,,,
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,comorbidity,asthma,no asthma,OR,1.37,1.29,1.45,yes,1.76,1.66,1.88,"age, sex, BMI, smoking status, hypertension",1436,37203,7078,250565
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,comorbidity,diabetes,no diabetes,OR,2.36,2.27,2.46,yes,,,,,3350,35289,9960,247683
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,comorbidity,stroke,no stroke,OR,1.91,1.77,2.08,yes,,,,,772,37867,2715,254928
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,gender,female,male,OR,0.99,0.97,1.01,yes,1.08,1.03,1.13,"age, sex, BMI, smoking status, hypertension",21388,17251,143289,114354
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,gender,male,female,OR,1.01,0.99,1.03,yes,,,,,17251,21388,114354,143289
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,smoking,current,never,OR,1.73,1.67,1.79,yes,1.48,1.36,1.62,"age, sex, BMI, smoking status, hypertension",4787,19777,20458,146220
389,Higbee 2022,Higbee et. al. (2022),https://dx.doi.org/10.1016/S2213-2600%2821%2900369-6,UK Biobank 2006-2010,gold,prism,no,351874,38639,smoking,ex,never,OR,1.14,1.12,1.17,yes,1,0.95,1.05,"age, sex, BMI, smoking status, hypertension",14075,19777,90965,146220
441,Kaise 2021,Kaise et. al. (2021),,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,age,50-59,40-49,OR,1.18,0.93,1.5,yes,,,,,147,189,647,981
441,Kaise 2021,Kaise et. al. (2021),,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,age,60-69,40-49,OR,1.05,0.78,1.42,yes,,,,,69,189,341,981
441,Kaise 2021,Kaise et. al. (2021),https://dx.doi.org/10.2147/COPD.S322041,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,comorbidity,asthma,no asthma,OR,1.8,1.35,2.41,yes,,,,,73,347,214,1832
441,Kaise 2021,Kaise et. al. (2021),https://dx.doi.org/10.2147/COPD.S322041,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,comorbidity,stroke,no stroke,OR,3.08,1.53,6.2,yes,,,,,13,407,21,2025
441,Kaise 2021,Kaise et. al. (2021),https://dx.doi.org/10.2147/COPD.S322041,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,gender,female,male,OR,0.45,0.36,0.57,yes,,,,,124,296,985,1061
441,Kaise 2021,Kaise et. al. (2021),https://dx.doi.org/10.2147/COPD.S322041,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,gender,male,female,OR,2.22,1.77,2.78,yes,,,,,296,124,1061,985
441,Kaise 2021,Kaise et. al. (2021),https://dx.doi.org/10.2147/COPD.S322041,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,smoking,current,never,OR,1.51,1.18,1.94,yes,,,,,133,178,467,944
441,Kaise 2021,Kaise et. al. (2021),https://dx.doi.org/10.2147/COPD.S322041,original study - OCEAN (Okinawa COPD casE finding AssessmeNt),gold,prism,no,2518,420,smoking,ex,never,OR,0.91,0.7,1.18,yes,,,,,109,178,634,944
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,bmi,obese,normal ,OR,1.3,1.15,1.48,no,1.31,1.15,1.48,"Age, sex, BMI, hypertension, diabetes, hypercholesterolemia, smoking, and alcohol-adjusted",,,,
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,comorbidity,diabetes,non,OR,1.58,1.35,1.84,no,1.51,1.29,1.78,"Age, sex, BMI, hypertension, diabetes, hypercholesterolemia, smoking, and alcohol-adjusted",,,,
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,comorbidity,hypertension,non,OR,1.3,1.15,1.48,no,1.31,1.14,1.5,"Age, sex, BMI, hypertension, diabetes, hypercholesterolemia, smoking, and alcohol-adjusted",,,,
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,comorbidity,stroke,non,OR,1.5,1.05,2.16,no,1.46,0.97,2.19,"Age, sex, BMI, hypertension, diabetes, hypercholesterolemia, smoking, and alcohol-adjusted",,,,
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,gender,female,male,OR,0.83,0.75,0.93,yes,,,,,936,627,8205,4572
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,gender,male,female,OR,1.2,1.08,1.34,yes,,,,,627,936,4572,8205
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,smoking,current,non,OR,1.64,1.42,1.9,yes,,,,,275,957,1501,8585
472,Kim 2022,Kim et. al. (2022),https://dx.doi.org/10.1159/000517599,KNHANES IV-VI (2007-2015),gold,prism,no,17515,1563,smoking,ex,non,OR,1.1,0.96,1.27,yes,,,,,301,957,2448,8585
510,Kwon 2024,Kwon et. al. (2024),https://dx.doi.org/10.1016/j.chemosphere.2024.142137,KNHANES (2010-2019),gold,rsp,no,22387,2535,gender,female,male,OR,0.58,0.53,0.63,yes,,,,,1227,1308,10565,6500
510,Kwon 2024,Kwon et. al. (2024),https://dx.doi.org/10.1016/j.chemosphere.2024.142137,KNHANES (2010-2019),gold,rsp,no,22387,2535,gender,male,female,OR,1.73,1.59,1.88,yes,,,,,1308,1227,6500,10565
510,Kwon 2024,Kwon et. al. (2024),https://dx.doi.org/10.1016/j.chemosphere.2024.142137,KNHANES (2010-2019),gold,rsp,no,22387,2535,smoking,current,non,OR,1.31,1.17,1.47,yes,,,,,458,1384,2772,10974
510,Kwon 2024,Kwon et. al. (2024),https://dx.doi.org/10.1016/j.chemosphere.2024.142137,KNHANES (2010-2019),gold,rsp,no,22387,2535,smoking,ex,non,OR,1.66,1.5,1.83,yes,,,,,693,1384,3319,10974
599,Mannino 2003,Mannino et. al. (2003a),,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,age,50-59,40-49,OR,1.86,1.41,2.46,yes,,,,,150,93,606,699
599,Mannino 2003,Mannino et. al. (2003a),,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,age,60-69,40-49,OR,1.74,1.29,2.35,yes,,,,,110,93,474,699
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,bmi,obese,normal >18.5-24,OR,1.55,1.21,1.98,yes,,,,,117,237,482,1513
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,bmi,overweight,normal >18.5-24,OR,0.99,0.8,1.22,yes,,,,,172,237,1112,1513
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,bmi,underweight,normal >18.5-24,OR,1.67,1.3,2.14,yes,,,,,113,237,432,1513
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,gender,female,male,OR,0.93,0.77,1.12,yes,,,,,291,221,1890,1332
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,gender,male,female,OR,1.08,0.89,1.3,yes,,,,,221,291,1332,1890
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,smoking,current,non,OR,1.72,1.4,2.11,yes,,,,,239,198,1043,1487
599,Mannino 2003,Mannino et. al. (2003a),https://dx.doi.org/10.1136/thorax.58.5.388,"NHANES I (1971-1975), follwed up till 1992 - only baseline characteristics were taken",gold,rsp,no,5542,510,smoking,ex,non,OR,0.85,0.64,1.12,yes,,,,,76,198,674,1487
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,bmi,obese,normal >18.5-24,OR,2.15,1.71,2.71,yes,,,,,181,148,971,1710
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,bmi,overweight,normal >18.5-24,OR,0.94,0.73,1.21,yes,,,,,121,148,1489,1710
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,bmi,underweight,normal >18.5-24,OR,5.48,3.39,8.86,yes,,,,,28,148,59,1710
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,comorbidity,cvd,no cvd,OR,2.08,1.38,3.13,yes,,,,,30,446,132,4088
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,comorbidity,diabetes,no diabetes,OR,2.16,1.56,3.01,yes,,,,,48,433,206,4022
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,gender,female,male,OR,1.29,1.07,1.56,yes,,,,,303,194,2325,1925
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,gender,male,female,OR,0.77,0.64,0.94,yes,,,,,194,303,1925,2325
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,smoking,current,non,OR,1.64,1.31,2.05,yes,,,,,129,293,714,2662
601,Mannino 2003,Mannino et. al. (2003b),https://dx.doi.org/10.1111/j.1365-2796.2003.01211.x,NHANES III 1988-1994 (phase 2 - 1991-94),gold,rsp,no,7503,495,smoking,ex,non,OR,0.78,0.6,1,yes,,,,,82,293,958,2662
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,age,50-59,40-49,OR,1.23,1.06,1.42,yes,,,,,485,518,1147,1506
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,age,60-69,40-49,OR,1.06,0.89,1.27,yes,,,,,259,518,708,1506
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,age,70-79,40-49,OR,1.08,0.85,1.39,yes,,,,,103,518,276,1506
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,bmi,obese,normal >18.5-24,OR,1.93,1.62,2.28,yes,,,,,436,340,726,1090
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,bmi,overweight,normal >18.5-24,OR,0.98,0.84,1.14,yes,,,,,553,340,1809,1090
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,bmi,underweight,normal >18.5-24,OR,3.46,2.19,5.47,yes,,,,,41,340,38,1090
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,gender,female,male,OR,1.43,1.26,1.62,yes,,,,,836,546,1920,1793
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,gender,male,female,OR,0.7,0.62,0.79,yes,,,,,546,836,1793,1920
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,smoking,current,non,OR,0.94,0.81,1.09,yes,,,,,346,590,1210,1936
603,Mannino 2012,Mannino et. al. (2012),,BOLD study,gold,prism,yes,9762,1382,smoking,ex,non,OR,2.58,2.21,3.01,yes,,,,,446,590,567,1936
636,Meghji 2016,Meghji et. al. (2016),https://dx.doi.org/10.1164/rccm.201509-1807OC,original,gold,rsp,yes,1057,756,bmi,obese,normal 18.5-24.5,,,,,,1.58,0.85,2.96,"age, sex, and variables correlated at p<0.2 in bivariate analysis",,,,
636,Meghji 2016,Meghji et. al. (2016),https://dx.doi.org/10.1164/rccm.201509-1807OC,original,gold,rsp,yes,1057,756,bmi,overweight,normal 18.5-24.5,OR,,,,,1.07,0.66,1.73,"age, sex, and variables correlated at p<0.2 in bivariate analysis",,,,
636,Meghji 2016,Meghji et. al. (2016),https://dx.doi.org/10.1164/rccm.201509-1807OC,original,gold,rsp,yes,1057,756,bmi,underweight,normal 18.5-24.5,OR,,,,,4.09,2.04,8.22,"age, sex, and variables correlated at p<0.2 in bivariate analysis",,,,
636,Meghji 2016,Meghji et. al. (2016),https://dx.doi.org/10.1164/rccm.201509-1807OC,original,gold,rsp,yes,1057,756,gender,female,male,OR,,,,,0.95,0.65,1.4,"age, sex, and variables correlated at p<0.2 in bivariate analysis",,,,
763,Perez-Padilla 2023,Perez-Padilla et. al. (2023),https://dx.doi.org/10.2147/COPD.S406208,PLATINO study,gold,prism,yes,2942,146,comorbidity,asthma,no asthma,OR,1.78,1.17,2.7,yes,,,,,31,115,298,1996
763,Perez-Padilla 2023,Perez-Padilla et. al. (2023),https://dx.doi.org/10.2147/COPD.S406208,PLATINO study,gold,prism,yes,2942,146,comorbidity,tuberculosis,no TB,OR,1.7,0.78,3.72,yes,,,,,7,139,69,2225
763,Perez-Padilla 2023,Perez-Padilla et. al. (2023),https://dx.doi.org/10.2147/COPD.S406208,PLATINO study,gold,prism,yes,2942,146,gender,female,male,OR,1.12,0.79,1.59,yes,,,,,93,53,1399,895
763,Perez-Padilla 2023,Perez-Padilla et. al. (2023),https://dx.doi.org/10.2147/COPD.S406208,PLATINO study,gold,prism,yes,2942,146,gender,male,female,OR,0.88,0.62,1.25,yes,,,,,53,93,895,1399
763,Perez-Padilla 2023,Perez-Padilla et. al. (2023),https://dx.doi.org/10.2147/COPD.S406208,PLATINO study,gold,prism,yes,2942,146,smoking,current,non-current,OR,1.32,0.93,1.87,yes,,,,,51,95,665,1629
916,Shiraishi 2022,Shiraishi et. al. (2022),https://dx.doi.org/10.1183/23120541.00063-2022,original,gold,prism,no,1818,173,gender,female,male,OR,0.76,0.55,1.06,yes,,,,,64,109,622,808
916,Shiraishi 2022,Shiraishi et. al. (2022),https://dx.doi.org/10.1183/23120541.00063-2022,original,gold,prism,no,1818,173,gender,male,female,OR,1.31,0.95,1.82,yes,,,,,109,64,808,622
916,Shiraishi 2022,Shiraishi et. al. (2022),https://dx.doi.org/10.1183/23120541.00063-2022,original,gold,prism,no,1818,173,smoking,current,non-current,OR,0.78,0.48,1.26,yes,,,,,57,30,366,150
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,bmi,obese,normal >18.5-24,OR,2.25,2.17,2.33,yes,,,,,4741,35059,14091,234625
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,bmi,overweight,normal >18.5-24,OR,1.73,1.7,1.76,yes,,,,,21566,35059,83491,234625
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,bmi,underweight,normal >18.5-24,OR,1.11,1.07,1.15,yes,,,,,4408,35059,26582,234625
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,comorbidity,diabetes,no diabetes,OR,2.91,2.83,3,yes,,,,,7556,58276,15302,343536
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,comorbidity,hypertension,no hypertension,OR,2.8,2.75,2.85,yes,,,,,23793,42039,60310,298528
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,gender,female,male,OR,1.26,1.24,1.28,yes,,,,,36955,28877,180633,178205
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,gender,male,female,OR,0.79,0.78,0.81,yes,,,,,28877,36955,178205,180633
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,smoking,current,non,OR,0.93,0.91,0.95,yes,,,,,10426,33495,66979,199966
921,Shu 2024,Shu et. al. (2024),https://dx.doi.org/10.1093/qjmed/hcae010,original,gold,prism,no,461183,65832,smoking,ex,non,OR,1.02,0.98,1.06,yes,,,,,3159,33495,18534,199966
928,Sin 2023,Sin et. al. (2023),,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,age,50-59,40-49,OR,1.37,1.09,1.71,yes,,,,,140,200,1697,3320
928,Sin 2023,Sin et. al. (2023),,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,age,60-69,40-49,OR,1.59,1.26,2,yes,,,,,131,200,1370,3320
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,bmi,underweight,normal 18.5-22.9,OR,3.09,1.77,5.38,yes,,,,,17,121,80,1759
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,comorbidity,cvd,no cvd,OR,1.47,0.76,2.84,yes,,,,,10,461,93,6294
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,comorbidity,diabetes,no diabetes,OR,1.65,1.19,2.29,yes,,,,,44,427,376,6011
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,comorbidity,hypertension,no hypertension,OR,1.51,1.19,1.91,yes,,,,,95,376,917,5470
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,gender,female,male,OR,0.73,0.6,0.88,yes,,,,,223,248,3529,2858
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,gender,male,female,OR,1.37,1.14,1.66,yes,,,,,248,223,2858,3529
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,smoking,current,never,OR,1.43,1.14,1.78,yes,,,,,129,260,1395,4009
928,Sin 2023,Sin et. al. (2023),https://dx.doi.org/10.1186/s12890-023-02451-2,KoGES (Korean Genome and Epidemiology Study) Ansan and Ansung study,gold,prism,no,7526,471,smoking,ex,never,OR,1.29,0.99,1.66,yes,,,,,82,260,983,4009
945,Soriano 2012,Soriano et. al. (2012),,EPI-SCAN,gold,rsp,no,3802,481,age,70-79,40-49,OR,7.87,6.81,10.65,no,7.41,5.21,10.54,"centre of study, age, gender, smoking, education, Charlson index score, BMI",,,,
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,bmi,obese,normal >18.5-24.9,OR,3.37,2.51,4.53,no,2.58,1.86,3.58,"centre of study, age, gender, smoking, education, Charlson index score, BMI",,,,
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,bmi,overweight,normal >18.5-24.9,OR,1.94,1.45,2.58,no,1.43,1.05,1.95,"centre of study, age, gender, smoking, education, Charlson index score, BMI",,,,
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,bmi,underweight,normal >18.5-24.9,OR,1.79,0.4,8.05,no,2.86,0.61,13.44,"centre of study, age, gender, smoking, education, Charlson index score, BMI",,,,
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,gender,female,male,OR,0.57,0.47,0.69,yes,,,,,208,273,1681,1249
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,gender,male,female,OR,1.77,1.45,2.15,no,1.82,1.43,2.42,"centre of study, age, gender, smoking, education, Charlson index score, BMI",,,,
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,smoking,current,non,OR,0.76,0.59,0.98,yes,,,,,98,222,758,1312
945,Soriano 2012,Soriano et. al. (2012),https://dx.doi.org/10.4104/pcrj.2012.00027,EPI-SCAN,gold,rsp,no,3802,481,smoking,ex,non,OR,1.1,0.88,1.38,yes,,,,,160,222,857,1312
950,Sperandio 2015,Sperandio et. al. (2015),,Epidemiological Study of Human Movement and Hypokinetic Diseases,gold,rsp,yes,374,37,age,continuous_age,,OR,,,,,1.01,0.91,1.12,"age, gender, race, level of education (higher education or not), self-reported CVD risk factors (SAH, diabetes, dyslipidemia, smoking, obesity, and physical inactivity),body composition (fat body mass), peripheral muscle function (PT of the quadriceps and biceps), postural balance (COP area while standing with eyes open), and cardiorespiratory fitness (peak VO2)",,,,
950,Sperandio 2015,Sperandio et. al. (2015),,Epidemiological Study of Human Movement and Hypokinetic Diseases,gold,rsp,yes,374,37,comorbidity,diabetes,no diabetes,OR,,,,,3.55,0.38,33.01,"age, gender, race, level of education (higher education or not), self-reported CVD risk factors (SAH, diabetes, dyslipidemia, smoking, obesity, and physical inactivity),body composition (fat body mass), peripheral muscle function (PT of the quadriceps and biceps), postural balance (COP area while standing with eyes open), and cardiorespiratory fitness (peak VO2)",,,,
950,Sperandio 2015,Sperandio et. al. (2015),,Epidemiological Study of Human Movement and Hypokinetic Diseases,gold,rsp,yes,374,37,comorbidity,hypertension,no hypertension,OR,,,,,17.51,1.7,184.82,"age, gender, race, level of education (higher education or not), self-reported CVD risk factors (SAH, diabetes, dyslipidemia, smoking, obesity, and physical inactivity),body composition (fat body mass), peripheral muscle function (PT of the quadriceps and biceps), postural balance (COP area while standing with eyes open), and cardiorespiratory fitness (peak VO2)",,,,
950,Sperandio 2015,Sperandio et. al. (2015),,Epidemiological Study of Human Movement and Hypokinetic Diseases,gold,rsp,yes,374,37,gender,female,male,OR,2.11,0.99,4.51,yes,,,,,27,10,189,148
950,Sperandio 2015,Sperandio et. al. (2015),,Epidemiological Study of Human Movement and Hypokinetic Diseases,gold,rsp,yes,374,37,gender,male,female,OR,0.47,0.22,1.01,yes,0.115,0.006,2.093,"age, gender, race, level of education (higher education or not), self-reported CVD risk factors (SAH, diabetes, dyslipidemia, smoking, obesity, and physical inactivity),body composition (fat body mass), peripheral muscle function (PT of the quadriceps and biceps), postural balance (COP area while standing with eyes open), and cardiorespiratory fitness (peak VO2)",10,27,148,189
950,Sperandio 2015,Sperandio et. al. (2015),,Epidemiological Study of Human Movement and Hypokinetic Diseases,gold,rsp,yes,374,37,smoking,current,not current smoking,OR,,,,,11.699,1.564,87.504,"age, gender, race, level of education (higher education or not), self-reported CVD risk factors (SAH, diabetes, dyslipidemia, smoking, obesity, and physical inactivity),body composition (fat body mass), peripheral muscle function (PT of the quadriceps and biceps), postural balance (COP area while standing with eyes open), and cardiorespiratory fitness (peak VO2)",,,,
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,comorbidity,asthma,no asthma,OR,2.15,1.68,2.74,yes,,,,,85,621,543,8515
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,comorbidity,diabetes,no diabetes,OR,3.16,2.46,4.06,yes,,,,,84,622,371,8687
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,comorbidity,hypertension,no hypertension,OR,1.63,1.37,1.94,yes,,,,,187,519,1639,7419
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,comorbidity,stroke,no stroke,OR,2.23,1.38,3.6,yes,,,,,20,686,118,8940
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,gender,female,male,OR,0.99,0.85,1.15,yes,,,,,326,380,4212,4846
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,gender,male,female,OR,1.01,0.87,1.18,yes,,,,,380,326,4846,4212
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,smoking,current,non,OR,1.44,1.17,1.77,yes,,,,,123,434,1168,5924
995,Tanabe 2022,Tanabe. et al. (2022),https://dx.doi.org/10.1016/j.resinv.2022.08.006,original - medical check up records,gold,prism,no,10139,706,smoking,ex,non,OR,1.03,0.85,1.25,yes,,,,,149,434,1966,5924
1015,Tran 2023,Tran et. al. (2023),https://dx.doi.org/10.1016/j.rmed.2023.107126,COPDGene,gold,prism,yes,5055,,smoking,current,ex-smoking,OR,1.25,1.05,1.48,yes,,,,,443,242,1965,1341
1059,Wan 2021,Wan et. al. (2021),,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,age,50-59,40-49,OR,1.11,1.01,1.21,yes,,,,,1428,797,11477,7082
1059,Wan 2021,Wan et. al. (2021),,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,age,60-69,40-49,OR,1.34,1.21,1.47,yes,,,,,1024,797,6815,7082
1059,Wan 2021,Wan et. al. (2021),,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,age,70-79,40-49,OR,1.37,1.23,1.53,yes,,,,,654,797,4239,7082
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,comorbidity,asthma,no asthma,OR,2.21,2.01,2.42,yes,,,,,627,3955,2657,37022
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,comorbidity,diabetes,no,OR,2.22,2.06,2.39,yes,,,,,1170,3412,5312,34367
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,comorbidity,heart_failure,no,OR,1.66,1.48,1.87,yes,,,,,353,4229,1899,37780
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,comorbidity,hypertension,no,OR,2.04,1.92,2.17,yes,,,,,2531,2051,14955,24724
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,comorbidity,stroke,no,OR,2.52,2.09,3.03,yes,,,,,147,4435,516,39163
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,gender,female,male,OR,1.06,0.99,1.13,yes,,,,,2764,1818,23398,16281
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,gender,male,female,OR,0.95,0.89,1.01,yes,,,,,1818,2764,16281,23398
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,smoking,current,non,OR,1.71,1.58,1.84,yes,,,,,1153,2091,6944,21476
1059,Wan 2021,Wan et. al. (2021),https://dx.doi.org/10.1001/jama.2021.20939,National Heart Lung and Blood Institute (NHLBI) Pooled Cohorts Study,gold,prism,no,53701,4582,smoking,ex,non,OR,1.22,1.14,1.31,yes,,,,,1338,2091,11259,21476
1068,Wang 2024,Wang et. al. (2024),https://dx.doi.org/10.1080/09603123.2024.2352609,NHANES 2007-2012,gold,rsp,not mentioned,4338,320,bmi,obese,normal <25,OR,2.09,1.57,2.78,yes,,,,,173,70,1424,1203
1068,Wang 2024,Wang et. al. (2024),https://dx.doi.org/10.1080/09603123.2024.2352609,NHANES 2007-2012,gold,rsp,not mentioned,4338,320,bmi,overweight,normal <25,OR,0.95,0.68,1.33,yes,,,,,77,70,1391,1203
1068,Wang 2024,Wang et. al. (2024),https://dx.doi.org/10.1080/09603123.2024.2352609,NHANES 2007-2012,gold,rsp,not mentioned,4338,320,gender,female,male,OR,0.85,0.68,1.07,yes,,,,,145,175,1980,2038
1068,Wang 2024,Wang et. al. (2024),https://dx.doi.org/10.1080/09603123.2024.2352609,NHANES 2007-2012,gold,rsp,not mentioned,4338,320,gender,male,female,OR,1.17,0.93,1.47,yes,,,,,175,145,2038,1980
1068,Wang 2024,Wang et. al. (2024),https://dx.doi.org/10.1080/09603123.2024.2352609,NHANES 2007-2012,gold,rsp,not mentioned,4338,320,smoking,current,non,OR,0.93,0.69,1.25,yes,,,,,64,166,917,2214
1068,Wang 2024,Wang et. al. (2024),https://dx.doi.org/10.1080/09603123.2024.2352609,NHANES 2007-2012,gold,rsp,not mentioned,4338,320,smoking,ex,non,OR,1.35,1.04,1.77,yes,,,,,90,166,887,2214
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,bmi,obese,non-obese,OR,2.13,1.72,2.64,yes,,,,,156,231,1007,3178
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,comorbidity,asthma,no asthma,OR,1.52,1.09,2.11,yes,,,,,45,342,334,3851
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,comorbidity,diabetes,no,OR,1.46,1.05,2.04,yes,,,,,44,343,338,3847
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,comorbidity,heart_failure,no,OR,3.56,2.32,5.48,yes,,,,,29,358,93,4092
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,comorbidity,hypertension,no,OR,1.74,1.34,2.27,yes,,,,,315,72,2992,1193
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,gender,female,male,OR,0.98,0.8,1.22,yes,,,,,224,163,2438,1747
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,gender,male,female,OR,1.02,0.82,1.25,yes,,,,,163,224,1747,2438
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,smoking,current,non,OR,1.84,1.31,2.59,yes,,,,,54,119,383,1555
1088,Wijnant 2020,Wijnant et. al. (2020),https://dx.doi.org/10.1183/13993003.01217-2019,Rotterdam Study phase 1 - 2009-2014,gold,prism,no,5487,387,smoking,ex,non,OR,1.24,0.99,1.57,yes,,,,,214,119,2247,1555
1113,Zhang 2024,Zhang et. al. (2024),https://dx.doi.org/10.1016/j.rmed.2023.107523,original,gold,prism,no,6994,1997,comorbidity,diabetes,no,OR,0.87,0.69,1.09,yes,,,,,112,1885,250,3645
1113,Zhang 2024,Zhang et. al. (2024),https://dx.doi.org/10.1016/j.rmed.2023.107523,original,gold,prism,no,6994,1997,comorbidity,hypertension,no,OR,0.79,0.71,0.88,yes,,,,,897,1100,1975,1920
1113,Zhang 2024,Zhang et. al. (2024),https://dx.doi.org/10.1016/j.rmed.2023.107523,original,gold,prism,no,6994,1997,gender,female,male,OR,0.6,0.54,0.67,yes,,,,,860,1137,2177,1718
1113,Zhang 2024,Zhang et. al. (2024),https://dx.doi.org/10.1016/j.rmed.2023.107523,original,gold,prism,no,6994,1997,gender,male,female,OR,1.68,1.5,1.87,yes,,,,,1137,860,1718,2177
1113,Zhang 2024,Zhang et. al. (2024),https://dx.doi.org/10.1016/j.rmed.2023.107523,original,gold,prism,no,6994,1997,smoking,current,non,OR,1.44,1.26,1.65,yes,,,,,470,1479,683,3097
1113,Zhang 2024,Zhang et. al. (2024),https://dx.doi.org/10.1016/j.rmed.2023.107523,original,gold,prism,no,6994,1997,smoking,ex,non,OR,0.87,0.62,1.23,yes,,,,,48,1479,115,3097
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,age,continuous_age,,OR,,,,,0.87,0.82,0.92,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",,,,
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,bmi,continuous,,OR,,,,,0.98,0.96,0.99,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",,,,
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,comorbidity,asthma,,OR,1.37,0.95,1.97,yes,,,,,35,951,221,8215
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,comorbidity,cvd,,OR,0.65,0.42,0.99,yes,1.58,1,2.39,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",26,357,180,1602
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,comorbidity,diabetes,,OR,,,,,1.21,0.9,1.6,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",,,,
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,comorbidity,tuberculosis,,OR,0.57,0.4,0.82,yes,1.29,0.9,1.81,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",38,357,297,1602
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,gender,female,male,OR,1.49,1.31,1.71,yes,1.37,1.18,1.58,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",601,385,4311,4125
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,gender,male,female,OR,0.67,0.59,0.77,yes,,,,,385,601,4125,4311
1128,Siddharthan 2024,Siddharthan et. al. (2024),https://dx.doi.org/10.1016/S2214-109X(24)00233-X,Global Excellence in COPD outcomes (GECo study),gold,prism,yes,10664,986,smoking,current,non,OR,0.37,0.29,0.47,yes,0.71,0.56,0.89,"age (decile), sex (male or female), BMI (continuous), daily cigarette smoking (yes or no), biomass use (yes or no),
and comorbidities (yes or no)",98,357,1181,1602
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,alcohol,frequent,never,OR,0.44,0.43,0.45,yes,,,,,33431,7290,233136,22300
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,alcohol,sometimes,never,OR,0.6,0.58,0.62,yes,,,,,14354,7290,73079,22300
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,bmi,overweight,normal 18.5-24.9,OR,1.28,1.11,1.47,yes,,,,,43043,225,216213,1443
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,bmi,underweight,normal 18.5-24.9,OR,0.69,0.6,0.8,yes,,,,,11975,225,111064,1443
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,comorbidity,asthma,,OR,1.67,1.63,1.72,yes,,,,,7286,48079,27294,301660
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,comorbidity,chronic kidney disease,,OR,1.22,1.15,1.29,yes,,,,,1583,53782,7753,321201
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,comorbidity,cvd,,OR,2.6,2.5,2.7,yes,,,,,4278,51087,10273,318681
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,comorbidity,diabetes,,OR,3.45,3.34,3.57,yes,,,,,5496,49869,10179,318775
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,comorbidity,hypertension,,OR,1.68,1.65,1.71,yes,,,,,33816,21549,158899,170055
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,gender,female,male,OR,0.17,0.17,0.17,yes,,,,,25594,29771,191079,37875
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,gender,male,female,OR,5.87,5.75,5.99,yes,,,,,29771,25594,37875,191079
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,smoking,current,non,OR,1.67,1.62,1.72,yes,,,,,6808,29508,26401,190701
1129,Kang 2024,Kang et. al. (2024),https://dx.doi.org/10.1186/s12916-024-03836-8,UK Biobank 2006-2010,gold,prism,no,420002,55365,smoking,ex,non,OR,1.08,1.06,1.11,yes,,,,,18561,29508,110591,190713
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,comorbidity,asthma,,OR,1.98,1.69,2.33,yes,,,,,184,1283,1660,22950
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,comorbidity,asthma,,OR,1.51,1.26,1.8,yes,,,,,145,1330,1660,22950
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,comorbidity,chronic bronchitis,,OR,2.22,1.83,2.7,yes,1.86,1.52,2.28,"age, sex, smoking status, educationlevel, BMI, and study site",123,1344,974,23636
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,comorbidity,chronic bronchitis,,OR,2.01,1.64,2.46,yes,1.68,1.37,2.07,"age, sex, smoking status, educationlevel, BMI, and study site",113,1362,974,23636
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,comorbidity,diabetes,,OR,2.77,2.4,3.21,yes,1.91,1.63,2.24,"age, sex, smoking status, educationlevel, BMI, and study site",243,1224,1644,22966
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,comorbidity,diabetes,,OR,2.96,2.57,3.42,yes,2.04,1.75,2.38,"age, sex, smoking status, educationlevel, BMI, and study site",258,1217,1644,22966
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,comorbidity,ischaemic heart disease,,OR,2.67,1.98,3.61,yes,2.2,1.62,3.26,"age, sex, smoking status, educationlevel, BMI, and study site",51,1416,327,24283
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,comorbidity,ischaemic heart disease,,OR,2.55,1.88,3.46,yes,2.01,1.47,2.76,"age, sex, smoking status, educationlevel, BMI, and study site",49,1426,327,24283
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,comorbidity,rheumatic disease,,OR,1.74,1.39,2.18,yes,1.51,1.2,1.91,"age, sex, smoking status, educationlevel, BMI, and study site",87,1380,860,23750
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,comorbidity,rheumatic disease,,OR,1.9,1.53,2.37,yes,1.73,1.38,2.16,"age, sex, smoking status, educationlevel, BMI, and study site",95,1380,860,23750
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,gender,female,male,OR,0.76,0.69,0.85,yes,,,,,788,679,14857,9753
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,gender,female,male,OR,0.68,0.62,0.76,yes,,,,,753,722,14857,9753
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,gender,male,female,OR,1.31,1.18,1.46,yes,,,,,679,788,9753,14857
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,gender,male,female,OR,1.46,1.31,1.62,yes,,,,,722,753,9753,14857
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,smoking,current,non,OR,2.08,1.8,2.4,yes,1.81,1.56,2.11,"age, sex, smoking status, educationlevel, BMI, and study site",292,672,2710,12993
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,smoking,current,non,OR,1.45,1.24,1.69,yes,1.24,1.06,1.45,"age, sex, smoking status, educationlevel, BMI, and study site",231,765,2710,12993
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,prism,yes,28855,1467,smoking,ex,non,OR,1.09,0.97,1.23,yes,0.94,0.83,1.07,"age, sex, smoking status, educationlevel, BMI, and study site",503,672,8907,12993
1133,Toren 2024,Toren et. al. (2024),https://dx.doi.org/10.1513/AnnalsATS.202403-242OC,Swedish CArdioPulmonary bioImage Study (SCAPIS),gold,rsp,yes,28855,1475,smoking,ex,non,OR,0.91,0.81,1.03,yes,0.78,0.69,0.88,"age, sex, smoking status, educationlevel, BMI, and study site",479,765,8907,12993
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,age,>70,40-49,OR,1.06,1.06,1.07,yes,0.68,0.58,0.79,"age, sex, residence, smoking status, bmi",1086801,3026876,9191584,27210006
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,age,50-59,40-49,OR,1.22,1.22,1.22,yes,1.1,0.98,1.24,"age, sex, residence, smoking status, bmi",3134658,3026876,23051908,27210006
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,age,60-69,40-49,OR,1.15,1.15,1.16,yes,0.87,0.77,0.99,"age, sex, residence, smoking status, bmi",1733493,3026876,13495579,27210006
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,bmi,>25,<23,OR,1.28,1.27,1.28,yes,1.13,1.01,1.26,"age, sex, residence, smoking status, bmi",3826258,2901130,27210006,26334617
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,bmi,23-24.9,<23,OR,1.05,1.05,1.06,yes,1.01,0.9,1.14,"age, sex, residence, smoking status, bmi",2254439,2901130,19404454,26334617
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,comorbidity,abdominal obesity,,OR,,,,,1.48,1.31,1.68,"age, sex, residence, smoking status, bmi",,,,
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,comorbidity,diabetes,,OR,,,,,1.33,1.21,1.45,"age, sex, residence, smoking status, bmi",,,,
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,comorbidity,hypertension,,OR,,,,,1.27,1.16,1.39,"age, sex, residence, smoking status, bmi",,,,
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,comorbidity,metabolic syndrome,,OR,,,,,1.43,1.29,1.59,"age, sex, residence, smoking status, bmi",,,,
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,gender,female,male,OR,0.76,0.76,0.76,yes,1.02,0.89,1.18,"age, sex, residence, smoking status, bmi",4481932,4499895,41289178,31659899
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,gender,male,female,OR,1.31,1.31,1.31,yes,,,,,4499895,4481932,31659899,41289178
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,smoking,current,non,OR,1.37,1.37,1.38,yes,1.08,0.92,1.26,"age, sex, residence, smoking status, bmi",1949056,4957969,12911987,45082530
1134,Choi 2024,Choi et. al. (2024),https://dx.doi.org/10.1371/journal.pone.0307302,KNHANES (2010-2019),gold,prism,no,32949,3803,smoking,ex,non,OR,1.26,1.26,1.26,yes,1.01,0.87,1.19,"age, sex, residence, smoking status, bmi",2074802,4957969,14954561,45082530
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,age,>60,<40,OR,4.45,1,19.76,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,age,40-49,<40,OR,4.32,1.15,16.26,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,age,50-59,<40,OR,3.67,0.95,14.27,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,bmi,obese,<25,OR,3.75,1.61,8.71,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,bmi,overweight,<25,OR,1.48,0.73,3.03,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,comorbidity,coronary heart disease,,OR,1.66,0.45,6.29,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,comorbidity,diabetes,,OR,3.849,1.043,14.2,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,comorbidity,hypertension,,OR,3.45,1.53,7.77,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,comorbidity,tuberculosis,,OR,13.68,5.5,34.05,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,gender,male,female,OR,1.91,0.28,1.43,no,,,,,,,,
1254,Xia 2025,Xia et. al. (2025),https://dx.doi.org/10.1371/journal.pone.0318546,original,gold,prism,no,627,63,smoking,current,non,OR,2.59,1.31,5.15,no,,,,,,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,age,>80,40-49,OR,0.89,0.47,1.69,yes,,,,,12,135,79,795
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,age,50-59,40-49,OR,0.93,0.72,1.21,yes,,,,,128,135,810,795
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,age,60-69,40-49,OR,0.71,0.52,0.97,yes,,,,,70,135,578,795
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,age,70-79,40-49,OR,1.18,0.81,1.72,yes,,,,,42,135,210,795
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,bmi,obese,18.5-25,OR,1.81,1.37,2.38,yes,,,,,171,91,738,709
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,bmi,overweight,18.5-25,OR,0.77,0.58,1.04,yes,,,,,107,91,1079,709
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,bmi,underweight,18.5-25,OR,3.9,1.53,9.9,yes,,,,,7,91,14,709
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,asthma,,OR,,,,,2.02,1.35,2.96,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,asthma (ever-diagnosed),,OR,,,,,1.8,1.3,2.46,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,cvd,,OR,,,,,2.56,1.7,3.81,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,diabetes,,OR,,,,,3.07,2.12,4.39,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,hypertension,,OR,,,,,1.93,1.44,2.6,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,lung cancer,,OR,,,,,13.2,3.16,58.1,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,comorbidity,stroke,,OR,,,,,1.85,0.85,3.73,"age, sex, Indigenous ethnicity, bmi, smoking habits, socioeconomic status",,,,
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,gender,female,male,OR,0.98,0.79,1.21,yes,,,,,204,183,1377,1205
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,gender,male,female,OR,1.03,0.83,1.27,yes,,,,,183,204,1205,1377
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,smoking,current,non,OR,3.25,2.43,4.34,yes,,,,,94,167,228,1315
1257,Zhou 2025,Zhou et. al. (2025),https://dx.doi.org/10.1177/14799731241312687,Burden of Obstructive Lung Disease (BOLD) Australia,gold,prism,yes,3518,387,smoking,ex,non,OR,0.95,0.75,1.22,yes,,,,,126,167,1039,1315
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,alcohol,current,non,OR,0.93,0.88,0.98,yes,,,,,2386,9041,5356,18807
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,alcohol,ex,non,OR,0.95,0.84,1.08,yes,,,,,364,9041,799,18807
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,bmi,obese,18.5-25,OR,1.35,1.24,1.47,yes,,,,,1006,6145,1668,13773
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,bmi,overweight,18.5-25,OR,1.08,1.03,1.13,yes,,,,,4311,6145,8986,13773
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,bmi,underweight,18.5-25,OR,1.41,1.23,1.62,yes,,,,,349,6145,554,13773
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,comorbidity,asthma,,OR,2.16,1.73,2.69,yes,,,,,161,11663,159,24889
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,comorbidity,copd,,OR,1.62,1.24,2.14,yes,,,,,91,11733,119,24929
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,comorbidity,cvd,,OR,1.18,1.09,1.28,yes,,,,,1004,10820,1826,23222
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,comorbidity,diabetes,,OR,1.26,1.14,1.4,yes,,,,,634,11190,1076,23972
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,comorbidity,hypertension,,OR,1.2,1.15,1.25,yes,,,,,5221,6603,9958,15090
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,gender,female,male,OR,0.88,0.84,0.92,yes,,,,,6736,5088,15053,9995
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,gender,male,female,OR,1.14,1.09,1.19,yes,,,,,5088,6736,9995,15053
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,smoking,current,non,OR,1.07,1.02,1.13,yes,,,,,2697,8535,5433,18474
1265,Li 2025,Li et. al. (2025),https://www.medrxiv.org/content/10.1101/2025.02.04.25321451v1.full.pdf,Prospective Urban Rural Epidemiology (PURE) study,gold,prism,no,40279,11824,smoking,ex,non,OR,1.12,1.01,1.24,yes,,,,,592,8535,1141,18474
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,comorbidity,asthma,,OR,1.96,1.68,2.28,yes,,,,,220,1232,1667,18302
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,comorbidity,cancer,,OR,1.89,1.56,2.28,yes,,,,,132,1320,1004,18965
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,comorbidity,chronic bronchitis,,OR,2.23,1.83,2.73,yes,,,,,120,1332,774,19195
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,comorbidity,diabetes,,OR,2.73,2.36,3.15,yes,,,,,258,1194,1466,18503
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,comorbidity,emphysema,,OR,4.03,2.59,6.25,yes,,,,,26,1426,90,19879
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,comorbidity,hypertension,,OR,2.12,1.9,2.37,yes,,,,,596,856,4936,15033
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,gender,female,male,OR,1.1,0.99,1.22,yes,,,,,805,647,10601,9368
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,gender,male,female,OR,0.91,0.82,1.01,yes,,,,,647,805,9368,10601
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,smoking,current,non,OR,1.56,1.38,1.77,yes,,,,,442,664,4701,11025
1289,Xiao 2025,Xiao et. al. (2025),https://www.dovepress.com/risk-of-all-cause-mortality-in-us-adults-with-preserved-ratio-impaired-peer-reviewed-fulltext-article-COPD,NHANES 1988-1994 and NHANES 2007-2012,gold,prism,no,24691,1452,smoking,ex,non,OR,1.35,1.18,1.55,yes,,,,,346,664,4243,11025
8888,Qiao 2018,Qiao et. al. (2018),doi:10.16386/j.cjpccd.issn.1004-6194.2017.01.006,original,gold,rsp,yes,1082,104,bmi,overweight,normal ,OR,0.94,0.74,1.14,yes,,,,,,,,
8888,Qiao 2018,Qiao et. al. (2018),doi:10.16386/j.cjpccd.issn.1004-6194.2017.01.006,original,gold,rsp,yes,1082,104,comorbidity,diabetes,non,OR,1.78,0.94,3.37,yes,,,,,,,,
8888,Qiao 2018,Qiao et. al. (2018),doi:10.16386/j.cjpccd.issn.1004-6194.2017.01.006,original,gold,rsp,yes,1082,104,comorbidity,hypertension,non,OR,1.58,0.89,2.82,yes,,,,,,,,
8888,Qiao 2018,Qiao et. al. (2018),doi:10.16386/j.cjpccd.issn.1004-6194.2017.01.006,original,gold,rsp,yes,1082,104,gender,male,female,OR,1.01,1.06,5.23,yes,,,,,,,,
8888,Qiao 2018,Qiao et. al. (2018),doi:10.16386/j.cjpccd.issn.1004-6194.2017.01.006,original,gold,rsp,yes,1082,104,smoking,current,non,OR,2.23,1.12,4.47,yes,,,,,,,,
